Cargando…
Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes
Glioma is the most malignant primary tumor of the central nervous system and is characterized by an extremely low overall survival. Recent breakthroughs in cancer therapy using immune checkpoint blockade have attracted significant attention. However, despite representing the most promising (immunoth...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729019/ https://www.ncbi.nlm.nih.gov/pubmed/33329549 http://dx.doi.org/10.3389/fimmu.2020.578877 |